AusBiotech announces formation of the AusMedtech Health Economics Expert Panel
Wednesday, 09 November, 2011
The AusMedtech Health Economics Expert Panel to be chaired by Mr Warren Bingham, President of Given Imaging and committee member of the AusMedtech National Advisory Group, will provide advice on issues and trends impacting the medical device and diagnostics sector in Australia, related to:
- Health economics and assessment;
- Reforms in the Health Technology Assessment framework; and
- Processes for public funding and reimbursement of medical devices in Australia.
The Panel comprising of up to 10 appointed members will bring together a cross-section of representatives from small to large Australian medical device companies, overseas manufacturers and suppliers, regulatory and industry consultants.
Dr Anna Lavelle, CEO of AusBiotech, said: “Responding to members’ needs, AusBiotech is pleased to launch this new panel which will focus specifically on the health economic issues for the fast-growing and developing medical technology sector.”
“The Panel will enable us to be more active in advocacy related to regulatory processes and approvals for medical devices and diagnostics in Australia, and thereby more supportive to emerging medical technologies."
The Panel will provide expert advice to AusBiotech’s CEO on specific industry matters to provide support to AusBiotech/AusMedtech members.
The AusMedtech Health Economics Expert Panel includes appointed members:
- (Chair) Mr Warren Bingham (Given Imaging)
- Ms Beth McIntyre (Dibbs Barker)
- Dr Jari Hyvarinen (Advanced Surgical and Design Manufacture Limited)
- Ms Judy Readman (Enterix Australia)
- Mr Domenic Tilden (THEMA Consulting)
'Anti-reward' brain network helps explain cocaine addiction
A new study identifies a specific 'anti-reward' network deep in the brain that undergoes...
Intense grief linked to higher risk of death for a decade
Researchers have found that bereaved people with persistent high levels of intense grief use more...
COVID vaccine candidate protects against multiple variants
By targeting features shared by a range of coronaviruses, the vaccine is designed to offer...